These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23945244)

  • 1. [Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer].
    Zhang X; Hou Y; Niu Z; Li W; Meng X; Zhang N; Yang S
    Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):411-6. PubMed ID: 23945244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
    Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
    Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.
    Decock J; Obermajer N; Vozelj S; Hendrickx W; Paridaens R; Kos J
    Int J Biol Markers; 2008; 23(3):161-8. PubMed ID: 18949742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients.
    Chen Q; Fei J; Wu L; Jiang Z; Wu Y; Zheng Y; Lu G
    Oncol Lett; 2011 Jul; 2(4):693-699. PubMed ID: 22848251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
    Tumminello FM; Flandina C; Crescimanno M; Leto G
    Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.
    Naumnik W; Niklińska W; Ossolińska M; Chyczewska E
    Folia Histochem Cytobiol; 2009; 47(2):207-13. PubMed ID: 19995705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Shi GP; Urbonavicius S; Henneberg EW; Lindholt JS
    Atherosclerosis; 2011 Jun; 216(2):440-5. PubMed ID: 21388623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma cathepsin S and cystatin C levels and coronary plaque morphology of mild to moderate lesions: an in vivo study using intravascular ultrasound.
    Gu FF; Lü SZ; Chen YD; Zhou YJ; Song XT; Jin ZN; Liu H
    Chin Med J (Engl); 2009 Dec; 122(23):2820-6. PubMed ID: 20092784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD.
    Nakajima T; Nakamura H; Owen CA; Yoshida S; Tsuduki K; Chubachi S; Shirahata T; Mashimo S; Nakamura M; Takahashi S; Minematsu N; Tateno H; Fujishima S; Asano K; Celli BR; Betsuyaku T
    Dis Markers; 2016; 2016():4093870. PubMed ID: 27994288
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
    Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
    Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study.
    Lv BJ; Lindholt JS; Cheng X; Wang J; Shi GP
    PLoS One; 2012; 7(7):e41813. PubMed ID: 22844527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis.
    Haves-Zburof D; Paperna T; Gour-Lavie A; Mandel I; Glass-Marmor L; Miller A
    J Cell Mol Med; 2011 Nov; 15(11):2421-9. PubMed ID: 21143385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis.
    Tejera-Segura B; de Vera-González AM; López-Mejías R; González-Gay MA; Ferraz-Amaro I
    Clin Exp Rheumatol; 2016; 34(2):230-5. PubMed ID: 26941186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum cathepsin S in patients with atherosclerosis and diabetes.
    Liu J; Ma L; Yang J; Ren A; Sun Z; Yan G; Sun J; Fu H; Xu W; Hu C; Shi GP
    Atherosclerosis; 2006 Jun; 186(2):411-9. PubMed ID: 16140306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.